GSK completes $2B acquisition of Bellus Health

seekingalpha2023-06-29

GSK (NYSE:GSK) has formally closed its $2B acquisition of Canadian biotech Bellus Health (NASDAQ:BLU). Bellus (BLU) shareholders approved the deal on June 16. The deal, announced in April, gives the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2347821497?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1442119524/image_1442119524.jpg","is_english":true,"pubTime":"2023-06-29 00:51","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2347821497","market":"us","top_or_hot":-1,"title":"GSK completes $2B acquisition of Bellus Health","media":"seekingalpha","content":"<div>\n<p>GSK (NYSE:GSK) has formally closed its $2B acquisition of Canadian biotech Bellus Health (NASDAQ:BLU).\nBellus (BLU) shareholders approved the deal on June 16.\nThe deal, announced in April, gives the ...</p>\n\n<a href=\"https://seekingalpha.com/news/3983808-gsk-completes-2b-acquisition-bellus-health\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GSK completes $2B acquisition of Bellus Health</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGSK completes $2B acquisition of Bellus Health\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-06-29 00:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3983808-gsk-completes-2b-acquisition-bellus-health><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GSK (NYSE:GSK) has formally closed its $2B acquisition of Canadian biotech Bellus Health (NASDAQ:BLU).\nBellus (BLU) shareholders approved the deal on June 16.\nThe deal, announced in April, gives the ...</p>\n\n<a href=\"https://seekingalpha.com/news/3983808-gsk-completes-2b-acquisition-bellus-health\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4563","symbol_name":"昨日强势股","start_time":0,"source_url":"https://seekingalpha.com/news/3983808-gsk-completes-2b-acquisition-bellus-health","article_id":"2347821497","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1442119524/image_1442119524.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2347821497","pubTimestamp":1687971106,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"GSK  has formally closedits $2B acquisition ofCanadian biotech Bellus Health .Bellus  shareholders approved the deal on June 16.The deal, announced in April, gives the UK drug giant access to camlipixant, currently in a phase 3 trial for refractory chronic cough.GSK's Zantac Settlement: Financial Impact And Investor Outlook","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4563":"昨日强势股","LU1829250122.USD":"高盛欧洲核心股票组合Acc","BK4585":"ETF&股票定投概念","GSK":"葛兰素史克","BK4139":"生物科技","GSK.UK":"葛兰素史克","BK4588":"碎股","BK4007":"制药","BK4532":"文艺复兴科技持仓"},"translate_title":"葛兰素史克完成20亿美元收购贝鲁斯健康公司","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BLU":1,"GSK":1,"GSK.UK":0.6},"content_text":"GSK (NYSE:GSK) has formally closed its $2B acquisition of Canadian biotech Bellus Health (NASDAQ:BLU).\nBellus (BLU) shareholders approved the deal on June 16.\nThe deal, announced in April, gives the UK drug giant access to camlipixant, currently in a phase 3 trial for refractory chronic cough.\n\nMore on GSK\n\nGSK's Zantac Settlement: Financial Impact And Investor Outlook\nGSK: A Biopharma Giant On Sale","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2347821497"}